Biotech Stocks Of 2022 Which Delivered Double-digit Gains
Biotech stocks are fraught with high risk, but they also present high-reward opportunities for investors.
Let’s take a look at some of the healthcare stocks that delivered double-digit returns since our reporting.
Want to know more about biotech stocks with high gains? Why not take a look at “52 Biotech Stocks Of 2022 With Triple-Digit Gains”?
Headlines Published Date Published Price Maximum Price Since Publishing Last Closing Price Max Gain % GOSS – Gossamer Bio Rallies On $120 Mln Investment By Institutional Investors Jul. 13 $7.62 $15.20 $2.73 99.48% APEN – Premarket Mover: Apollo Gains Weight On De Novo Marketing Authorization For Certain Devices Jul. 13 $5.17 $10.30 $9.97 99.23% VIGL – Why Vigil Neuroscience Is Turning Heads Sep. 22 $8.50 $16.77 $12.54 97.29% BCLI – Brainstorm Plunges As FDA Refuses To Review ALS Treatment Nov. 10 $1.20 $2.33 $1.92 94.17% DCPH – Deciphering DCPH… Apr. 26 $10.83 $20.88 $15.31 92.80% SRTS – Sensus Healthcare Delivers Strong Q1 Results May. 6 $7.92 $15.25 $6.42 92.55% APEN – Apollo Endosurgery To Report Q2 Results On Aug.2 Jul. 25 $5.36 $10.30 $9.97 92.16% VACC – Vaccitech To Report Additional Interim Efficacy Data On VTP-300 In Chronic HBV Infection Next Month May. 16 $3.91 $7.45 $2.29 90.54% KPTI – Will The Momentum Continue In Karyopharm? Jan. 11 $7.75 $14.73 $3.10 90.06% CLPT – ClearPoint Makes It Clear – Revenue And Footprint To Expand Feb. 16 $8.93 $16.96 $8.40 89.92% DAWN – Day One Skyrockets On Positive Study Results Of Tovorafenib In Pediatric Brain Tumor Jun. 13 $14.94 $28.35 $21.42 89.76% TRVI – Trevi Therapeutics’ PRISM Trial Of Haduvio In Prurigo Nodularis Meets Goals Jun. 29 $2.47 $4.68 $2.11 89.47% ABCL – AbCellera Biologics – Waiting For Its Heyday… May. 18 $7.92 $14.97 $10.21 89.02% RLMD – Relmada’s REL-1017 Demonstrates Lack Of Abuse Potential In Second Study Too Feb. 23 $20.50 $38.68 $3.37 88.68% ISEE – IVERIC’s Phase III Geographic Atrophy Trial Meets Goal, Shares Jump Sep. 6 $12.96 $24.33 $22.32 87.73% RVPH – Reviva – Waiting To RECOVER Oct. 12 $3.25 $6.10 $3.75 87.69% SIGA – SIGA Technologies Rallies As WHO Declares Monkeypox A Global Health Emergency Jul. 25 $14.45 $26.99 $7.64 86.78% AGIO – Will Agios’ Pyrukynd Secure Blockbuster Tag? Jun. 23 $18.72 $34.76 $29.71 85.68% ESPR – Will Esperion’s Q1 Results Beat Estimates? Apr. 21 $4.80 $8.87 $6.14 84.79% BVNKF – Bavarian Back In Focus As Monkeypox Cases Rise May. 20 $31.57 $58.02 $30.90 83.78% OCUL – Ocular Therapeutix Q1 Results – Hit Or Miss? May. 2 $3.57 $6.53 $2.73 82.91% ACCD – Accolade’s Revenue For Q2 Of Fiscal 2023 To Grow 12% To 14% Jul. 1 $7.55 $13.80 $8.46 82.78% LABP – Landos – Bracing For A Busy Quarter Ahead Jul. 1 $0.75 $1.37 $0.26 82.67% TCRT – Alaunos To Make Presentations At The International Cancer Immunotherapy Conference Aug. 25 $2.20 $4.01 $0.59 82.27% ZYXI – Zynex: What’s Making News? Jun. 13 $7.99 $14.55 $13.32 82.10% MCRB – When Will Microbiome Therapy Join The Recurrent C.diff Infection Armamentarium? Sep. 2 $5.22 $9.49 $5.75 81.80% OLK – Exploring Olink… Jan. 21 $13.76 $24.93 $23.00 81.18% ZLAB – Zai Lab Q1 Revenue Jumps More Than Twofold May. 11 $30.00 $53.95 $32.59 79.83% MDGL – Madrigal Pharma Reports Encouraging Data From NASH Trial; Shares Gain 15% Jan. 31 $59.20 $105.93 $63.80 78.94% BNR – Will Burning Rock Regain Ground? Jun. 1 $2.40 $4.24 $2.55 76.67% MASS – 908 Devices Sees Revenue Growing At 23-30% In FY22 Jun. 6 $14.76 $26.00 $8.49 76.15% AMLX – Amylyx Pharma Ascends 16% Jul. 5 $22.63 $39.78 $35.67 75.78% ALDX – Aldeyra’s Crossover Trial Of Dry Eye Disease Drug Achieves Goals; Stock Up Over 15% Jul. 12 $4.55 $7.99 $6.32 75.60% XAIR – Beyond Air Breathes Easy Jun. 29 $6.70 $11.76 $6.17 75.52% VERU – Veru Rises 17% On Submission Of EUA Application For Its Covid-19 Treatment Jun. 7 $14.00 $24.55 $4.99 75.36% CGEM – Cullinan Oncology Soars On Deal With Taiho Pharma May. 12 $9.08 $15.89 $11.44 75.00% PSTX – Poseida Inks Blockbuster Strategic Global Collaboration Agreement With Roche Aug. 3 $3.68 $6.43 $0.81 74.73% CANO – Cano Aiming For 75%-81% Revenue Growth In FY22 Jul. 7 $5.59 $9.75 $1.21 74.42% KNSA – Kiniksa To Report Prurigo Nodularis Trial Data In 2H 2022 Jun. 22 $9.88 $17.20 $15.87 74.09% PEAR – Will Pear Bloom? Jan. 31 $3.92 $6.74 $1.62 71.94% TXMD – TherapeuticsMD Jumps On Receiving Equity Investment From Rubric Capital Aug. 1 $6.81 $11.69 $7.09 71.66% CUE – Cue Biopharma Rallies On Getting Fast Track Designation For Its Head And Neck Cancer Drug Candidate Oct. 4 $2.45 $4.19 $2.70 71.02% APLT – Applied Therapeutics To Present AT-007 Data At The Annual Clinical Genetics Meeting Mar. 17 $1.60 $2.73 $0.76 70.63% RPTX – Repare Therapeutics Rallies In Pre-market On Collaboration With Roche For Camonsertib Jun. 2 $10.97 $18.68 $15.34 70.28% AHCO – AdaptHealth Looks Good, Can It Make You Rich? Apr. 13 $16.20 $27.48 $19.75 69.63% GH – Guardant Health’s Revenue To Grow By 23% To 26% In 2022 May. 24 $37.00 $62.75 $30.06 69.59% PTCT – PTC Therapeutics’ Upstaza Just One Step Away From Getting Approval In Europe May. 20 $32.83 $55.58 $39.22 69.30% STRO – Sutro Soars On Deal With Astellas To Advance Novel Immunostimulatory Antibody-drug Conjugates Jun. 28 $4.98 $8.37 $7.30 68.07% VIRX – Viracta Therapeutics Anticipates Data From Nana-val Trial In 2H 2022 Jun. 30 $3.43 $5.75 $1.78 67.64% ASRT – Assertio Expects 2022 Product Sales To Grow 16% To 24% Mar. 28 $2.65 $4.44 $3.66 67.55% FIXX – FDA Lifts Clinical Hold On Homology Medicines’ Phenylketonuria Gene Therapy Trial Jun. 14 $1.97 $3.30 $1.37 67.51% TSHA – Taysha Gene Awaits Regulatory Feedback For Gene Therapy TSHA-120 Jun. 7 $3.07 $5.09 65.80% MYNZ – Mainz Acquires Rights To Biomarkers With Potential To Enhance ColoAlert’s Utility; Stock Rises Jan. 5 $18.21 $30.00 $1.08 64.74% AURA – Throwing Light On Aura… Jul. 8 $15.08 $24.83 $12.17 64.66% DH – Definitive Healthcare Foresees 33% To 35% Revenue Growth In 2022 May. 27 $18.31 $30.11 $2.14 64.45% MYOV – Myovant Sciences Gets Expanded FDA Approval For Myfembree; Stock Up Aug. 8 $16.41 $26.93 $26.89 64.11% PLRX – Premarket Mover: Pliant Therapeutics Soars On INTEGRIS-IPF Study Data Jul. 11 $16.01 $26.25 $18.69 63.96% ARDX – Will Ardelyx’ Xphozah Make It To The Finish Line? Oct. 13 $1.34 $2.19 $1.96 63.43% HAE – Haemonetics Adds 15% On Reporting Q4 Profit, Beating Estimates May. 10 $53.00 $86.58 $78.33 63.36% RCKT – Rocket Pharma – Yet To Take Off… Sep. 14 $14.11 $22.89 $22.24 62.23% AUVI – Applied UV Soars As Its Distributor Gets Exclusive Deal In Pakistan Jun. 9 $2.60 $4.20 $1.08 61.54% ATHX – Athersys To Provide Update On Clinical Programs On Feb.2 Jan. 27 $20.75 $33.25 $3.16 60.24% BMEA – Biomea Fusion – What’s In Store For 2022? Jan. 4 $8.89 $14.20 $8.06 59.73% DYN – Dyne Gearing Up For Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 Trials Jul. 14 $9.79 $15.63 $13.52 59.65% AXNX – Axonics On Track To Post Over 30% Revenue Growth In 2022 May. 26 $50.13 $79.92 $59.81 59.43% RAD – Rite Aid Corp. Climbs 8% After Raising Annual Revenue Outlook Above Estimates Jun. 23 $7.29 $11.61 $4.27 59.26% BTTX – Will BTTX See Better Days Ahead? Apr. 5 $2.05 $3.23 $1.49 57.56% TCDA – Will Veverimer Take The Crown As 1st Therapy To Treat Metabolic Acidosis And Slow CKD Progression? Jun. 15 $8.80 $13.85 $0.17 57.39% SGFY – Signify Health Sees Significant Momentum Heading Into H2 Aug. 5 $19.00 $29.88 $28.54 57.26% MRUS – Will Merus Get A Boost From ENRGy Trial Data? May. 31 $19.62 $30.81 $13.21 57.03% OKYO – What’s Making News At OKYO Pharma? May. 25 $2.20 $3.45 $2.26 56.82% SNDX – Syndax Pharma – For The Long Haul Mar. 2 $16.95 $26.51 $24.42 56.40% CTIC – What’s Making News At CTI BioPharma? Apr. 6 $4.99 $7.80 $5.71 56.31% DCGO – A Quick Look At DocGo… Feb. 10 $7.30 $11.41 $6.94 56.30% AXSM – Axsome Rises As Investors Cheer FDA Approval Of Major Depressive Disorder Drug Aug. 19 $51.89 $80.87 $78.40 55.85% DSGN – Is DT-216 Well-designed? Jul. 14 $16.89 $26.30 $8.76 55.71% ESPR – Esperion – Waiting For A Clear Outcome Jun. 21 $5.70 $8.87 $6.14 55.61% NVNO – A Quick Look At EnVVeno Medical… Jul. 12 $5.10 $7.93 $5.23 55.49% ASND – Will Ascendis Make An Ascent? Jun. 23 $86.55 $134.52 $118.60 55.42% CRIS – Curis Rises On TakeAim Lymphoma, TakeAim Leukemia Data Presentation Jun. 6 $1.14 $1.77 $0.50 55.26% INMD – InMode Up 12% As Prel. Results Come In Above Street View; Ups Guidance Jul. 12 $25.99 $40.29 $36.33 55.02% PRAX – Praxis Precision To Report Aria Study Data In June May. 12 $8.60 $13.33 $2.28 55.00% PRAX – Praxis At New Low As Study Of Its PRAX-114 For MDD Does Not Achieve Primary Goal Jun. 6 $3.16 $4.89 $2.28 54.75% NTRA – Natera Expects 23% To 26% Revenue Growth In 2022 Apr. 19 $37.50 $57.88 $43.32 54.35% PRCT – What’s Driving PROCEPT BioRobotics’ Revenue? Jun. 27 $34.00 $52.40 $43.00 54.12% AMEH – Apollo Medical Expects FY2022 Revenue To Grow 36% To 40% Jun. 3 $37.69 $58.00 $31.14 53.89% CUTR – Cutera Up On FDA Approval Of Its AviClear Acne Treatment Device Mar. 25 $48.41 $74.38 $45.57 53.65% AKYA – Akoya Biosciences To Report Q4 Results On Mar.14 Mar. 11 $10.79 $16.57 $12.22 53.57% TCDA – Will Tricida Prove Its VALOR? Sep. 23 $8.60 $13.12 $0.17 52.56% OM – At The Outset… Jul. 25 $17.42 $26.48 $25.25 52.01% RNAZ – TransCode To Advance Lead Candidate Into Clinical Trial In 2H 2022 Feb. 14 $2.03 $3.08 $0.43 51.72% ALPN – Alpine Immune’s Phase I NEON-2 Trial Placed On Partial Clinical Hold Mar. 7 $6.81 $10.30 $6.82 51.25% ALBO – Will Albireo Pharma Assert Its Position In Rare Liver Disease Drug Market? Jan. 6 $24.91 $37.63 $20.29 51.06% ADPT – Adaptive Biotechnologies Expects Nearly 20% To 26% Revenue Growth In FY22 Jun. 27 $8.75 $13.21 $8.01 50.97% DRIO – What’s Making News At DarioHealth? Apr. 28 $5.11 $7.69 $3.98 50.49% AGL – Why Agilon Health Is Worth A Look? Jun. 13 $18.85 $28.36 $17.23 50.45% MPLN – MultiPlan Sees 4% To 10% Revenue Growth In 2022 May. 12 $4.12 $6.19 $1.57 50.24% EIGR – Eiger BioPharmaceuticals Soars On Positive Study Results From Its Covid-19 Treatment Mar. 17 $6.67 $10.02 $1.12 50.22% NKTX – Nkarta To Report Additional Data For Two Engineered Natural Killer Cell Programs In 2H 2022 Jun. 21 $12.31 $18.48 $7.03 50.12% PYPD – Will PolyPid’s SHIELDs Make A Mark? Mar. 15 $4.60 $6.90 $0.75 50.00% LFMD – LifeMD Revenue Grows 60% In Q1 May. 16 $2.15 $3.22 $2.27 49.77% HARP – Harpoon To Report Phase I Data Of HPN328 In June May. 13 $1.93 $2.89 $0.68 49.74% EXAS – Exact Sciences – On An Accelerated Path To Profitability? Nov. 7 $37.80 $56.52 $51.92 49.52% ZYME – Zymeworks Inks Deal With Jazz As It Gears Up For Phase 3 Biliary Tract Cancer Trial Data Oct. 19 $5.88 $8.73 #N/A 48.47% EQRX – What’s The Buzz At EQRx? May. 16 $4.08 $6.05 $2.18 48.28% BTTX – Will BTTX See Better Days Ahead? Feb. 4 $3.44 $5.10 $1.49 48.26% TMCI – Treace Medical – Working Towards Establishing Lapiplasty As Standard Of Care For Bunion Treatment Jul. 28 $16.90 $25.02 $22.95 48.05% KMPH – KemPharm To Report Cardiovascular Safety Trial Data Of SDX In Q3 Apr. 25 $4.70 $6.92 $4.51 47.23% REVB – Revelation Bio Bracing For A Busy Year? Feb. 23 $1.96 $2.88 $0.21 46.94% QDEL – QuidelOrtho Q3 Revenue To Beat Wall Street Estimates Oct. 13 $69.80 $102.00 $82.59 46.13% PDSB – HUTCHMED’s Gastric Cancer Trial Meets One Of The Two Primary Endpoints Nov. 14 $6.90 $10.06 $9.34 45.80% ABIO – ARCA Biopharma Plunges As COVID-19 Trial Fails To Meet Primary Goal Apr. 1 $1.78 $2.59 $2.43 45.51% PODD – Insulet Gets FDA Nod For Omnipod 5, The World’s First Tubeless Automated Insulin Delivery System Jan. 28 $220.00 $320.00 $298.99 45.45% PRTK – Paratek Sees Demand Trends For Lead Drug NUZYRA To Continue Aug. 4 $2.52 $3.65 $1.78 44.84% NOVN – Novan To File For Approval Of Molluscum Contagiosum Treatment In Q4 Jun. 16 $2.30 $3.33 $1.26 44.78% SLGL – Sol-Gel Awaits Facelift Jul. 15 $4.76 $6.89 $4.56 44.75% OLMA – Olema To Present At The 34th EORTC-NCI-AACR Symposium Oct. 13 $2.85 $4.11 $2.33 44.21% TXMD – TherapeuticsMD To Divest VitaCare To GoodRx Mar. 7 $16.07 $23.00 $7.09 43.12% SMTI – Sanara MedTech – Gaining Traction Aug. 17 $28.00 $39.99 $39.10 42.82% CTKB – Cytek Biosciences Expects FY22 Revenue To Grow 25%-31% Jul. 13 $11.26 $16.05 $10.49 42.54% VOR – Vor Bio To Report Acute Myeloid Leukemia Trial Data In 2H22 Jun. 13 $5.32 $7.57 $7.07 42.29% TCMD – Tactile Systems Expects Revenue To Grow 13-15% In 2022 Feb. 24 $15.21 $21.62 $11.46 42.14% VRDN – Viridian Catches Eyes Aug. 15 $20.01 $27.95 $27.88 39.68% GMDA – What’s On Tap For Gamida This Year? Jan. 27 $3.38 $4.72 $1.22 39.64% CLVS – Clovis Oncology Soars On Positive Data From Monotherapy Arm Of ATHENA Trial Mar. 31 $2.33 $3.25 $0.08 39.48% AUGX – Augmedix Expects Revenue Growth Of 43% To 44% In Q4 Feb. 2 $2.42 $3.37 $1.15 39.26% MRSN – Mersana Inks Option Agreement With GSK For Antibody-drug Conjugate XMT-2056; Stock Up Aug. 9 $6.00 $8.34 $6.51 39.00% CERT – A Second Look At Certara Nov. 8 $13.30 $18.47 $16.17 38.87% AMLX – Amylyx Pharma Gearing Up For FDA Decision Sep. 27 $28.68 $39.78 $35.67 38.70% ATXS – Astria Shines… Sep. 6 $9.31 $12.86 $11.81 38.13% APYX – Premarket Mover: Apyx Medical Gets FDA Clearance For Renuvion APR Handpiece Jul. 18 $8.12 $11.16 $2.00 37.44% AMYT – Will Amryt Pharma’s Q4 Results Lag Or Trump Estimates? Mar. 8 $6.50 $8.90 $7.03 36.92% CDMO – Avid’s Fiscal 2023 Revenue Expected To Increase 17% To 21% Jun. 30 $15.00 $20.47 $13.83 36.47% MYNZ – Mainz Commences International Study Of ColoAlert, Results Expected By Early 2023 Feb. 4 $13.67 $18.63 $7.08 36.28% SLP – Simulations Plus To Report Q3 Financial Results On July 6 Jul. 4 $49.65 $67.59 $37.96 36.13% HCA – HCA Healthcare Drops 8% On Lower Quarterly Profit, Revenue Oct. 21 $183.58 $249.00 $239.05 35.64% YMAB – Will Y-mAbs’ Second Rare Disease Product Get FDA Nod? Jul. 5 $15.10 $20.48 $5.00 35.63% PCVX – Vaxcyte Rallies On Pneumococcal Conjugate Vaccine Trial Results Oct. 24 $35.15 $47.67 $45.80 35.62% VKTX – Viking Therapeutics To Resume Phase Ib Trial Of VK0214 In X-ALD As FDA Lifts Clinical Hold Jul. 19 $3.45 $4.65 $4.02 34.78% ARGX – Argenx’ Phase 3 ADAPT-SC Trial In Generalized Myasthenia Gravis Hits Goals Mar. 22 $302.91 $407.93 $385.81 34.67% BLPH – How Soon Can Bellerophon REBUILD Itself? Jul. 18 $1.29 $1.73 $0.77 34.11% TPST – What’s Brewing In Tempest? May. 9 $3.10 $4.15 $1.36 33.87% BIOL – Will BIOLASE Bring The Smile Back On Investors’ Face? Jun. 27 $4.44 $5.94 $0.62 33.78% ZNTL – Zentalis Secures $25Mln Equity Investment Apr. 27 $24.31 $32.34 $19.81 33.03% HARP – Harpoon Therapeutics: HPN217 Receives FDA Fast Track Designation Mar. 2 $4.10 $5.45 $0.68 32.93% IMPL – NeuroMetrix Soars On Receipt Of Breakthrough Designation From FDA For Quell Technology Jan. 19 $8.10 $10.75 $3.60 32.72% BMRA – Biomerica’s H. Pylori Antigen Test Awaits FDA Word Oct. 3 $3.96 $5.25 $3.49 32.58% LVTX – Lava Therapeutics To Present At J.P. Morgan Healthcare Conference Today Jan. 12 $5.58 $7.38 $3.65 32.26% ALT – Altimmune Gears Up For NAFLD Trial Results Aug. 17 $17.87 $23.49 $11.48 31.45% XERS – Xeris To Report Q1 Results Tomorrow May. 10 $1.88 $2.47 $1.29 31.38% PRVB – MacroGenics Soars On Milestone Payment From Provention Bio For FDA Approval Of Teplizumab Nov. 18 $7.50 $9.85 $9.28 31.33% IRIX – For Your Eyes Only… Jul. 1 $2.66 $3.49 $2.23 31.20% CMAX – Care To Take A Look At CareMax? Jul. 26 $6.48 $8.47 $3.13 30.71% XGN – Will Exagen’s Q2 Results Trump Or Miss Estimates Jul. 11 $6.87 $8.96 $2.47 30.42% AVXL – Anavex Life Clawing Back Yesterday’s Loss? Feb. 2 $11.69 $15.24 $8.64 30.37% ELDN – Eledon Pharma To Report ALS Trial Data In June May. 19 $3.04 $3.95 $2.49 29.93% SAGE – Sage Therapeutics To Present LUMINARY Study Results Of SAGE-718 In Alzheimer’s On Apr.5 Apr. 1 $33.98 $44.07 $40.26 29.69% HCAT – What’s The Next Catalyst For HCAT? Jun. 2 $14.12 $18.30 $10.79 29.60% MXCT – MaxCyte – Encouraged By Ongoing Growth Of SPL Portfolio Sep. 28 $5.82 $7.50 $5.34 28.87% ATEC – Alphatec – Gaining A Footing? Feb. 17 $10.62 $13.65 $10.71 28.53% PGNY – Premarket Mover: Progyny Soars On Upbeat Revenue, Outlook Aug. 5 $36.20 $46.50 $31.83 28.45% EXEL – Will Exelixis Excel Or Flunk This Year? Jan. 18 $18.24 $23.40 $15.94 28.29% NKTR – Nektar Therapeutics Plunges On Disappointing Melanoma Trial Results Mar. 14 $5.00 $6.40 $2.66 28.00% AKYA – Is Akoya Biosciences A Good Bet? Jul. 5 $12.95 $16.57 $12.22 27.95% MXCT – Time To Set Sight On MaxCyte? Feb. 4 $6.07 $7.76 $5.34 27.84% STVN – Stevanato Expects Nearly 11-12% Revenue Growth In FY22 Jun. 22 $15.19 $19.41 $17.50 27.78% CODX – Will Co-Diagnostics’ Monkeypox PCR Test Pay Off? Jul. 1 $5.58 $7.13 $2.53 27.78% BLFS – BioLife Sees Growth In Biostorage Services Platform In 2022 And Beyond Mar. 15 $21.11 $26.96 $17.58 27.71% MDGL – Madrigal – Gearing Up For MAESTRO-NASH Data Sep. 26 $64.99 $83.00 $63.80 27.71% BTAI – Will Sales Of BioXcel’s Agitation Drug Make A Splash? Jul. 11 $16.07 $20.18 $20.05 25.58% IPHA – Innate Pharma Awaits TELLOMAK Trial Data Jun. 21 $2.56 $3.20 $1.90 25.00% ANGO – AngioDynamics Delivers Strong Q4 Results; Provides Upbeat Sales Outlook Jul. 12 $19.84 $24.74 $12.28 24.70% COLL – Will 2023 Be A Banner Year For Collegium Pharma? Nov. 7 $18.74 $23.27 $22.75 24.17% BGNE – BeiGene: What’s Making News? Jun. 24 $169.53 $210.51 $205.00 24.17% VLON – Vallon Pharma Flunks Pivotal ADHD Trial; Stock Plunges Mar. 21 $2.16 $2.68 $0.30 24.07% APLS – Premarket Mover: Apellis To Face FDA In November Jul. 19 $56.42 $70.00 $53.00 24.07% EXEL – Exelixis Gains On Better-than-expected Quarterly Results Feb. 18 $18.87 $23.40 $15.94 24.01% AUTL – Will 2022 Be A Transformational Year For Autolus? Mar. 9 $3.82 $4.73 $1.76 23.82% MDXG – MiMedx – Expanding Placental Portfolio Aug. 3 $3.57 $4.42 $2.95 23.81% NAUT – What’s Making News At Nautilus Biotech? Apr. 21 $4.10 $5.07 $1.55 23.66% ALEC – Alector – Pioneering Immuno-neurology Jul. 5 $10.93 $13.50 $9.07 23.51% JANX – Janux Therapeutics – Transitions Into Clinical Stage Oct. 20 $15.44 $19.05 $12.45 23.38% DVAX – Dynavax Technologies – On Track For A Second Consecutive Year Of Profitability Jul. 13 $14.17 $17.48 $11.17 23.36% SLS – SELLAS Life To Report Ovarian Cancer Trial Data In Mid-2022 Mar. 17 $6.00 $7.40 $2.35 23.33% LEGN – Can Legend Carve Out A Niche For Carvykti? Oct. 24 $45.72 $56.25 $50.95 23.03% AGTI – Agiliti Expects 12% To 14% Revenue Growth In 2022 May. 18 $18.36 $22.53 $16.85 22.71% MDRX – Allscripts Healthcare Rises As Prel. Q4 Revenue Better Than View, On Share Buyback Jan. 25 $19.00 $23.25 $17.78 22.37% BBIO – A Walk Through BridgeBio Jul. 8 $10.34 $12.64 $9.26 22.24% EXAI – Exscientia Soars On $5.2Bln Deal With Sanofi Jan. 7 $20.24 $24.74 $4.51 22.23% OSUR – OraSure – Growth For Sure? Nov. 10 $4.47 $5.46 $5.01 22.15% ARQT – Arcutis Biotherapeutics: One Down, Four To Go Jun. 24 $22.44 $27.40 $15.96 22.10% IMGN – ImmunoGen To Report Q2 Results On July 29 Jul. 15 $5.43 $6.63 $5.00 22.10% MMSI – This Stock Merits Attention Oct. 27 $62.71 $76.14 $71.26 21.42% AXGN – AxoGen Foresees Double-digit Revenue Growth In 2022 Sep. 16 $11.29 $13.66 $10.54 20.99% HSTM – Will HealthStream’s Q2 Results Trump Estimates? Jul. 15 $22.02 $26.62 $24.58 20.89% RVMD – Revolution Medicines – Focusing On RAS-targeted Cancer Therapies Nov. 25 $21.48 $25.72 $24.30 19.74% CPRX – Catalyst Pharma Stock Hits All-time High Sep. 9 $15.38 $18.39 $16.00 19.57% BVS – Will Bioventus Walk The Talk? Feb. 28 $12.63 $15.10 $2.66 19.56% HRMY – Will Harmony Biosciences’ Q3 Results Beat Estimates? Oct. 28 $52.09 $62.09 $55.68 19.20% FNA – Paragon 28 Sees 16%-19% Revenue Growth In FY22 Jul. 6 $17.75 $21.15 $20.14 19.15% ADPT – Adaptive Biotechnologies – On Path To Profitability? Nov. 4 $8.29 $9.87 $8.01 19.06% CASI – CASI Pharma – It’s Not All About Evomela Aug. 30 $4.10 $4.86 $1.78 18.54% PPBT – Purple Biotech Recouping Some Of Yesterday’s Losses? Apr. 12 $3.00 $3.55 $1.59 18.33% FNCH – Finch Therapeutics Through The PRISM… Aug. 24 $2.45 $2.89 $0.69 17.96% EIGR – Eiger BioPharma Awaits TOGETHER Trial Data Later This Month Mar. 14 $8.54 $10.02 $1.12 17.33% ANIK – Anika To Report Q3 Results On Nov.8 Oct. 28 $27.74 $32.51 $29.09 17.20% CERT – Certara Expects FY22 Revenue To Grow Nearly 22% To 26% Jun. 30 $21.09 $24.66 $16.17 16.93% MYNZ – Mainz Biomed Up Over 12%; Here’s Why… Feb. 23 $15.25 $17.81 $7.08 16.79% MEDP – Medpace – At A Steady Pace Oct. 25 $202.45 $235.72 $206.00 16.43% MASI – Ardelyx’ Chronic Kidney Disease Drug Scores Positive Recommendation From FDA Panel Nov. 17 $129.91 $150.87 $142.59 16.13% PHAT – Will Phathom Pharma’s Vonoprazan Cross FDA Finish Line? Feb. 10 $17.19 $19.95 $10.79 16.06% ITCI – Intra-Cellular Therapies’ Caplyta Sees Encouraging Uptake Trends May. 11 $52.65 $61.00 $51.05 15.86% SNDX – Revisiting Syndax… Sep. 20 $22.97 $26.51 $24.42 15.41% AZYO – Aziyo Biologics Hits New High, What Next? Oct. 25 $7.82 $9.01 $3.64 15.22% CGEN – Compugen To Present At The American Association For Cancer Research In April Mar. 9 $3.10 $3.57 $0.81 15.16% DMTK – Will DermTech Regain Its Lost Sheen? Jul. 21 $7.76 $8.93 $2.05 15.08% LHDX – Lucira Expects Q4 Revenue To Grow Nearly Fourfold Sequentially Feb. 9 $4.95 $5.67 $0.21 14.55% EIGR – Eiger Beckons Investors Jul. 14 $8.64 $9.89 $1.12 14.47% CDXC – Will ChromaDex Walk The Talk? Mar. 8 $2.62 $2.99 $1.50 14.12% CALT – Calliditas Announces Commercial Launch Of Kidney Disease Drug In The U.S. Jan. 28 $20.36 $23.01 $19.00 13.02% PDCO – Patterson Boosts EPS Outlook On Continued Strong Momentum Mar. 4 $31.38 $35.29 $27.53 12.46% AIRS – Will Q4 Results Help AirSculpt Technologies Get Back In Shape? Mar. 10 $13.00 $14.60 $3.15 12.31% TIL – Instil Bio – On Track Aug. 12 $6.87 $7.71 $0.58 12.23% BTTX – Are Better Days Ahead For BTTX? Jul. 28 $2.50 $2.80 $1.49 12.00% ISO – Here’s Why You Need To Watch IsoPlexis Jul. 22 $3.43 $3.84 $0.71 11.95% CAPR – Capricor’s Cell Therapy – A New Hope For Duchenne Muscular Dystrophy Patients? Sep. 30 $5.88 $6.58 $3.75 11.90% CVAC – CureVac Rises On Preclinical Study Data Of Bivalent Second-Generation MRNA Vaccine Candidate Apr. 21 $18.03 $20.06 $6.81 11.26% CUTR – This Key Player In Medical Aesthetics Market Sees 10-12% Revenue Growth In FY22 Dec. 1 $47.69 $52.89 $45.57 10.90% ACIU – AC Immune Awaits 4 Data Readouts Jul. 13 $3.30 $3.65 $1.94 10.61% CSII – Can The Quarterly Results Lift Cardiovascular Systems’ Share Price? Nov. 1 $14.60 $16.11 $14.51 10.34% EGRX – Will The Recent Product Launches Add Wings To Eagle Pharma? Feb. 23 $48.88 $53.78 $29.33 10.02% Source: Read Full Article
|
